Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 16
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482689/260-10-45-16

+ Details

Name:	us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ndra_OptionsToPurchaseCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ndra_WarrantsToPurchaseCommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ndra_SharesIssuableUponConversionOfSeriesAConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ndra_PreFundedWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=ndra_IncrementalRestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Summary of Significant Accounting Policies - Schedule of Potentially Anti-Dilutive Shares (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025	Dec. 31, 2024
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded anti-dilutive	3,271,004	342,501	4,578,319	342,501	2,626,254	180,986
Potential equivalent shares excluded dilutive (in Dollars)	$ 1,151,215	$ 0
Options to purchase common stock [Member]
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded anti-dilutive	183	266	183	266	236	278
Warrants to purchase common stock [Member]
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded anti-dilutive	3,270,821	180,707	4,247,163	180,707	2,478,848	180,707
Shares issuable upon conversion of Series A Convertible Preferred Stock [Member]
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded anti-dilutive	0	1	1	1	1	1
Potential equivalent shares excluded dilutive (in Dollars)	$ 1	$ 0
Restricted Stock Units [Member]
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded anti-dilutive	0	161,527	330,972	161,527	147,169
Pre Funded Warrants Member
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded dilutive (in Dollars)	$ 976,323	$ 0
Incremental Restricted Stock Units [Member]
Schedule of Potentially Anti-Dilutive Shares [Line Items]
Potential equivalent shares excluded dilutive (in Dollars)	$ 174,891	$ 0